Qure.ai, a leader in medical imaging AI, achieves FDA breakthrough device status for its qSpot-TB solution, enhancing its regulatory standing alongside four FDA clearances and 61 EU MDR CE marks within 18 months. qSpot-TB,…
Continue Reading
The collaborative LungIMPACT study which is gathering real-world evidence of AI-assisted diagnosis of lung cancer, is welcoming East Suffolk and North Essex NHS Foundation Trust.The study brings together UK academia and NHS trusts and…
Continue Reading
Qure.ai, a trailblazer in medical imaging solutions, celebrates its 13th FDA clearance with qXR-LN, an AI-powered tool for lung nodule detection. This pioneering technology signifies Qure.ai’s supremacy in AI-driven advancements for plain film radiography…
Continue Reading
A digital health collaboration is to evaluate the use of AI in chest x-rays in Glasgow, with the Scottish government, University of Glasgow, Qure.ai and NHS Greater Glasgow and Clyde jointly working to assess…
Continue Reading
Qure.ai has announced its integration into deepc’s AI platform, deepcOS, in a strategic move that will help enhance patient care workflows and address the escalating demands on radiologists.The new partnership will see Qure.ai’s CE…
Continue Reading
The LungIMPACT trial – a collaborative study between UK academia, NHS hospitals and Qure.ai is now gathering real-world evidence of AI-assisted diagnosis of lung cancer.Using Qure.ai’s gXR solution, the LungIMPACT trial is triaging chest…
Continue Reading
Qure.ai, a prominent medical AI firm, has received FDA clearance for its qXR chest X-ray solution, enabling the triage of pneumothorax and pleural effusion. Qure.ai’s qXR algorithm demonstrated exceptional accuracy and rapid notification capabilities….
Continue Reading
A strategic partnership has been announced between Qure.ai and xWave Technologies, which will help support overworked radiology teams to order and report on the right diagnostic test, the first time.Medical artificial intelligence (AI) provider,…
Continue Reading
